Abstract:Abstract Background X-linked hypophosphatemia (XLHR) is the most common genetic form of hypophosphatemic rickets (HR), which is caused by phosphate regulating endopeptidase homolog X-linked (PHEX) gene mutation. At present, the genotype–phenotype relationship of XLHR and the pathogenic role of PHEX are not fully understood. Methods In this study, we summarized clinical features in a new cohort of 49 HR patients and detected 16 novel PHEX and 5 novel non-PHEX variants. Subsequently, we studied the pathogenesis of new variants by protein expression, glycosylation analysis, subcellular localization, and endopeptidase activity. Results The results showed that missense variants (Q189H and X750R) slightly reduced protein expression without obviously altering protein length and localization, whereas truncating variants significantly impaired the synthesis of PHEX and produced a shorter immature protein in cells. Interestingly, no evident correlation was observed between mutation types and clinical phenotypes. However, when we analyzed the relationship between PHEX activity and serum phosphorus level, we found that patients with low PHEX activity tended to have severe hypophosphatemia and high rickets severity score. Following this observation, we established 2 new knock-in XLHR mouse models with 2 novel Phex variants (c.T1349C and c.C426G, respectively) using CRISPR/Cas9 technology. Both mouse models demonstrated clinical manifestations of XLHR seen in patients, and PhexC426G mice showed more severe phenotype than PhexT1349C mice, which further confirmed the rationality of genotype–PHEX enzymatic activity correlation analysis. Conclusion Therefore, our findings demonstrated that novel PHEX variants could disrupt protein function via affecting protein synthesis, post-translational modification, cellular trafficking, and catalytic activity. Our study facilitates a better understanding of XLHR pathogenic mechanism and PHEX activity-phenotype correlation, which is of crucial importance for future diagnosis and treatment of XLHR.

A Novel Phex Mutation with Defective Glycosylation Causes Hypophosphatemia and Rickets in Mice

A de novo mosaic mutation of PHEX in a boy with hypophosphatemic rickets

Novel De Novo Nonsense Mutation of the PHEX Gene (p.lys50ter) in a Chinese Patient with Hypophosphatemic Rickets.

CRISPR/Cas9-mediated Mutation Ofphexin Rabbit Recapitulates Human X-linked Hypophosphatemia (XLH)

The Auditory Research of Pug Mice with X-linked Hypophosphatemia

Characterization of Novel PHEX Variants in X-linked Hypophosphatemic Rickets and Genotype-PHEX Activity Correlation

Identification of a Novel Missense Mutation of the PHEX Gene in a Large Chinese Family with X-Linked Hypophosphataemia

Seven Novel And. Six De Novo Phex Gene Mutations in Patients with Hypophosphatemic Rickets

Three Novel PHEX Gene Mutations in Four Chinese Families with X-linked Dominant Hypophosphatemic Rickets.

Identification of a p.Trp403* nonsense variant in PHEX causing X-linked hypophosphatemia by inhibiting p38 MAPK signaling.

Identification Of A Novel Nonsense Mutation In Polh In A Chinese Pedigree With Xeroderma Pigmentosum, Variant Type

Identification of Two Novel Mutations in the PHEX Gene in Chinese Patients with Hypophosphatemic Rickets/Osteomalacia

Glucose Metabolic Abnormality is Associated with Defective Mineral Homeostasis in Skeletal Disorder Mouse Model

Functional analysis of a de novo mutation c.1692 del A of the PHEX gene in a Chinese family with X-linked hypophosphataemic rickets.

Identification of Rare and Novel PHEX Variants in X-linked Hypophosphatemia

PHEX Neutralizing Agent Inhibits Dentin Formation in Mouse Tooth Germ.

A novel nonsense mutation and polymorphisms in the mouse hairless gene.

[Mutational Analysis and Prenatal Diagnosis in a Family Affected with Hypophosphatemic Rickets].

Author Response for "functional Characterization of PHEX Gene Variants in Children with X‐linked Hypophosphatemic Rickets Shows No Evidence of Genotype‐Phenotype Correlation"

Clinical and Genetic Analysis in a Large Chinese Cohort of Patients with X-linked Hypophosphatemia

PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia